Kevin Ellich analyst

Currently out of the existing stock ratings of Kevin Ellich, 16 are a BUY (38.1%), 22 are a HOLD (52.38%), 4 are a SELL (9.52%).

Kevin Ellich

Work Performance Price Targets & Ratings Chart

Analyst Kevin Ellich works with a stock forecast success ratio of 100% fulfilled within 360.78 days on average. Previously, Kevin Ellich worked at CRAIG HALLUM, PIPER SANDLER.

Kevin Ellich’s has documented 106 price targets and ratings displayed on 9 stocks. The coverage was on Healthcare, Financial Services sectors.

Most recent stock forecast was given on AMED, Amedisys at 31-Oct-2019.

Wall Street Analyst Kevin Ellich

Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for PETS (PETMED EXPRESS) at 10/17/2019. The price target of $20 was fulfilled within 4 days with a profit of $3.63 (22.17%) receiving and performance score of 55.44.

Average potential price target upside

AMED Amedisys PETS PetMed Express ZTS Zoetis HSIC Henry Schein LH Laboratory of America Holdings LHCG LHC Group NEOG Neogen TRUP Trupanion DGX Quest Diagnostics orporated

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

101

$9.95 (10.93%)

100

7 months 12 days ago

1/6 (16.67%)

$7.34 (7.84%)

45

Hold

101

$9.95 (10.93%)

84

8 months 26 days ago

1/3 (33.33%)

$10.16 (11.18%)

28

Hold

101

$9.95 (10.93%)

100

8 months 30 days ago

0/5 (0%)

$10.5 (11.60%)

Hold

98

$6.95 (7.63%)

200

9 months 20 days ago

11/15 (73.33%)

$6.69 (7.33%)

121

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Kevin Ellich?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?